According to Pliant Therapeutics's latest financial reports the company has a price-to-book ratio of 1.99.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.29 | -23.85% |
2022-12-31 | 3.01 | 22.92% |
2021-12-31 | 2.45 | -14.25% |
2020-12-31 | 2.85 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.6522 | -67.20% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 1.96 | -1.49% | ๐บ๐ธ USA |